ASCO 2025 Signals a New Chapter in Myelofibrosis Care The 2025 ASCO Annual Meeting delivered early visibility into where the...

Earlier this month, the US President signed a landmark executive order aimed at delivering “most favored nation” (MFN) pricing for...

We’re incredibly proud to announce that CSI has once again achieved the Platinum  EcoVadis  rating, for the second year in a row!  This...

In clinical trials, every element of the supply chain matters. From sourcing high-quality comparator drugs to managing timelines across...

Request A global listed Biotech company required large quantities of Eylea Pre-Filled Syringes (PFS)  sourced across both the EU and USA...

So are we! We’re pleased to share that Jonathan Miller , CSI’s Head of Operations, North America , will be attending Jefferies New York...

Client Request A leading global biopharmaceutical company approached CSI with an urgent need for the Fluarix QIV Southern Hemisphere...

CSI’s Strategic Approach to Mitigating Clinical Trial Supply Disruption Recent developments in U.S. trade policy are shaking up supply...

We’re proud to share that CSI is now fully registered and qualified with  SAM.gov  and BARDA , enabling us to support U.S....

A Global Pharmaceutical Sponsor’s Challenge A global pharmaceutical sponsor conducting a Phase III clinical trial needed Semaglutide, a...

CSI attended the Global Clinical Supplies Group (GCSG) US Conference in San Antonio, Texas, April 27th-30th. The event brought together...